Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Preceptorship on Advanced Non Resectable Hepatocellular Carcinoma, Biliary and Pancreatic Cancer 2019: Paris

ESMO Preceptorship Advanced NRHC Pancreatic France 2019 Banner
Start date
06 Dec 2019
End date
07 Dec 2019
Location
Paris, France

Learning objectives

  • To understand epidemiology, aetiology and molecular biology of hepatocellular carcinoma (HCC), biliary and pancreatic cancers
  • To understand multidisciplinary management and treatment of advanced non resectable hepatocellular carcinoma, biliary and pancreatic cancers
  • To learn about advances in the treatment and novel targets in hepatobiliary (HPB) carcinomas
  • To address complex cases management frequently encountered in daily practice, related with these diseases

Download the programme

How to apply

Application is via online form. During the application process you will be required to upload the following:

Application deadline

Applications for the course are now closed.

Who can apply?

While this course is primarily aimed at oncologists resident in Europe, application is open to all ESMO members.

To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.

What's included?

Successful applicants will benefit from complimentary course registration and accommodation.

Travel grant

In addition to the course registration and the hotel accommodation, a travel grant of maximum 600 euros is offered to selected applicants as a contribution versus their travel costs. The reimbursement will be processed after the course against original invoices/vouchers. Please be aware that visa costs are NOT covered by the travel grant and are the participant's responsibility.

Accreditation

The programme of this event has been accredited with 10 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

  • Konstantinos Kamposioras, United Kingdom
  • Julien Taieb, France

Venue and accommodation

Hotel California Paris Champs Elysées
16 Rue de Berry
75008 Paris

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings